10-day decitabine with venetoclax for newly diagnosed...

The Lancet Haematology 2020 / 10 Vol. 7; Iss. 10

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

DiNardo, Courtney D, Maiti, Abhishek, Rausch, Caitlin R, Pemmaraju, Naveen, Naqvi, Kiran, Daver, Naval G, Kadia, Tapan M, Borthakur, Gautam, Ohanian, Maro, Alvarado, Yesid, Issa, Ghayas C, Montalban-B
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(20)30210-6
Date:
October, 2020
File:
PDF, 630 KB
2020
Conversion to is in progress
Conversion to is failed